Clinical Trials | June 23, 2026
Zealand Pharma’s petrelintide delivers double-digit weight loss in next-gen obesity treatment
The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity
The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
The company hosted Symbiosis 2026 at its 2-acre manufacturing facility in Bengaluru, inaugurated in 2024
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
Partnership enters its ninth year after training over 2,200 young people and enabling employment for more than 1,750 beneficiaries through nursing assistant and digital skills programs
Report reveals growing confidence in AI-driven decision-making, but highlights persistent challenges in scaling digital investments and converting innovation into measurable business value
Market grows 12.1%; volume contribution improves as 9 out of 10 key therapies post double-digit growth
Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility
New facility will open by October 2026 and house 500 process development specialists
Patnaik stressed early diagnosis, rapid treatment, and aggressive surveillance as the backbone of elimination efforts
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
